Form 4 Tracker
Hims & Hers Health, Inc.
HIMS

92 insider filings · Latest: Oct 14, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 20, 2026Jan 20 9:34 PMOluyemi Okupe
Proposed Sale
27,204$30.47$828.9K—

View →

Dec 22, 2025Dec 22 10:00 PMOluyemi Okupe
Proposed Sale
32,160$35.05$1.1M—

View →

Dec 17, 2025Dec 17 3:26 PMCarroll Patrick Harrison
Proposed Sale
10,021$36.71$367.9K—

View →

Dec 17, 2025Dec 17 3:14 PMChi Michael
Proposed Sale
13,750$36.71$504.8K—

View →

Dec 17, 2025Dec 17 2:50 PMBecklund Irene
Proposed Sale
8,411$36.71$308.8K—

View →

Dec 17, 2025Dec 17 2:42 PMAutor Deborah M.
Proposed Sale
7,054$36.71$259.0K—

View →

Dec 9, 2025Dec 9 3:07 PMPerez Garcia Andrea G
Proposed Sale
2,500$39.17$97.9K—

View →

Nov 24, 2025Nov 24 3:03 PMBoughton Soleil
Proposed Sale
2,631$35.11$92.4K—

View →

Nov 10, 2025Nov 10 3:16 PMBoughton Soleil
Proposed Sale
2,637$42.53$112.2K—

View →

Oct 27, 2025Oct 27 1:42 PMBoughton Soleil
Proposed Sale
2,637$50.10$132.1K—

View →

Oct 16, 2025Oct 16 7:10 PMDudum Andrew
Proposed Sale
175,661$62.79$11.0M—

View →

Oct 13, 2025Oct 14 10:47 AMBoughton Soleil
Proposed Sale
2,637$54.38$143.4K—

View →

Oct 10, 2025Oct 10 3:26 PMChi Michael
Proposed Sale
900$58.25$52.4K—

View →

Sep 22, 2025Oct 1 9:52 PMOluyemi Okupe
Proposed Sale
154,958$59.12$9.2M—

View →

Oct 1, 2025Oct 1 3:34 PMChi Michael
Proposed Sale
250$56.00$14.0K—

View →

Sep 29, 2025Sep 29 1:51 PMBoughton Soleil
Proposed Sale
2,637$58.79$155.0K—

View →

Sep 24, 2025Sep 24 3:02 PMChi Michael
Proposed Sale
2,100$56.52$118.7K—

View →

Sep 22, 2025Sep 22 9:39 PMOluyemi Okupe
Proposed Sale
154,958$57.70$8.9M—

View →

Sep 17, 2025Sep 17 4:44 PMDudum Andrew
Proposed Sale
65,110$50.57$3.3M—

View →

Sep 17, 2025Sep 17 3:15 PMBoughton Soleil
Proposed Sale
2,637$50.50$133.2K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 13, 2026Mar 17 8:29 PMIrene BecklundPAO
Option Exercise
17,987—16,714(D)

View →

Mar 13, 2026Mar 17 8:28 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Option Exercise
164,369—229,805(D)

View →

Mar 13, 2026Mar 17 8:28 PMSoleil BoughtonChief Legal Officer
Option Exercise
41,421—74,194(D)

View →

Mar 13, 2026Mar 17 8:28 PMOluyemi OkupeChief Financial Officer
Option Exercise
105,200—137,790(D)

View →

Mar 11, 2026Mar 13 8:20 PMIrene BecklundPAO
Grant/Award
62,076—62,076(D)

View →

Mar 11, 2026Mar 13 8:20 PMMichael ChiChief Operating Officer
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMDeborah M. AutorDirector, Chief Policy Officer
Grant/Award
526,711—526,711(D)

View →

Mar 11, 2026Mar 13 8:20 PMPatrick Harrison CarrollDirector, Chief Medical Officer
Grant/Award
150,489—150,489(D)

View →

Mar 11, 2026Mar 13 8:20 PMSoleil BoughtonChief Legal Officer
Grant/Award
188,111—188,111(D)

View →

Mar 11, 2026Mar 13 8:20 PMMohamed ElshenawyCTO
Grant/Award
376,222—376,222(D)

View →

Mar 11, 2026Mar 13 8:20 PMAndrew DudumDirector, Chief Executive Officer, 10% Owner
Grant/Award
413,844—413,844(D)

View →

Mar 11, 2026Mar 13 8:20 PMOluyemi OkupeChief Financial Officer
Grant/Award
300,978—300,978(D)

View →

Feb 3, 2026Feb 4 9:13 PMOluyemi OkupeChief Financial Officer
Option Exercise
5,262$5.01144,051(D)

View →

Jan 20, 2026Jan 21 9:23 PMOluyemi OkupeChief Financial Officer
Option Exercise
9,067$11.5342,996(D)

View →

← Previous

Page 4 of 4